PFIZER INC Quarterly Revenues in USD from Q1 2022 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Pfizer Inc quarterly/annual Revenues history and growth rate from Q1 2022 to Q3 2024.
- Pfizer Inc Revenues for the quarter ending September 29, 2024 was $17.7B, a 31.2% increase year-over-year.
- Pfizer Inc Revenues for the twelve months ending September 29, 2024 was $59.4B, a 14.3% decline year-over-year.
- Pfizer Inc annual Revenues for 2023 was $58.5B, a 41.7% decline from 2022.
- Pfizer Inc annual Revenues for 2022 was $100B, a 23.4% increase from 2021.
- Pfizer Inc annual Revenues for 2021 was $81.3B, a 95.2% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)